Cryoport will expand its presence in the EMEA region through the acquisition of Belgium-based temperature-controlled supply chain solutions firm F-Airgate.

Cryoport, a temperature-controlled supply chain services company for the life sciences, has agreed to buy F-airgate, which will join Cryoport’s CRYOPDP business unit.

No financial details have been divulged.

Image: iStock/dk_photos

“This acquisition will expand our coverage in Europe and enable us to provide end-to-end solutions to both global and local customers in Belgium, which is a highly strategic area for Pharma/BioPharma activity in Europe,” said Jerrell Shelton, CEO of Cryoport.

Shelton added: “This tactical acquisition of F-Airgate will provide strategic impact for CRYOPDP as requests for local, on-the-ground operations in Belgium, a key market for BioPharma and R&D logistics, continues from many of our Biopharmaceutical/Pharma clients, as well as from potential new clients.”

Cryoport will retain F-Airgate’s Beligum facility, which expands its global footprint in the EMEA (Europe, Middle East, and Africa) region. This marks CRYOPDP’s 11^th site in Europe, and first facility in Belgium.

The firm says the site is in a strategic location for its customers in the life science industry who need temperature-controlled solutions.

“With F-Airgate now operating as part of our growing CRYOPDP business unit, we are confident this acquisition will provide us with additional capacity in the EMEA region through F-Airgate’s on-the-ground headquarters, agent network and numerous partnerships with local logistics providers,” said Shelton.

This is the latest in a string of acquisitions by Cryoport.

The firm acquired temperature-controlled logistics firm CRYOPDP in August 2020 for $58 million.

In the same month, Cryoport added cryogenic freezer systems firm MVE Biological Solutions for $320 million to boost its position in the temperature-controlled cell and gene therapy logistics space.